TV 7 1/2 1719 Pill - yellow capsule/oblong

Pill with imprint TV 7 1/2 1719 is Yellow, Capsule/Oblong and has been identified as Warfarin Sodium 7.5 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Warfarin is used in the treatment of Antiphospholipid Syndrome; Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery; Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery; Chronic Central Venous Catheterization; Prosthetic Heart Valves, Tissue Valves - Thrombosis Prophylaxis and belongs to the drug class coumarins and indandiones. for women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. for other pregnant populations: Not for use in pregnancy. Warfarin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 7 1/2 1719

Warfarin sodium 7.5 mg TV 7 1/2 1719 Front

Warfarin sodium 7.5 mg TV 7 1/2 1719 Back

Warfarin Sodium

Imprint: TV 7 1/2 1719
Strength: 7.5 mg
Color: Yellow
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Coumarins and indandiones
Pregnancy Category: D - Positive evidence of risk - for women with mechanical heart valves, X - Not for use in pregnancy - for other pregnant populations
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals USA Inc
National Drug Code (NDC): 00093-1719 (Discontinued)
Inactive Ingredients: silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, FD&C Yellow No. 5, aluminum oxide, FD&C Red No. 40
Note: Inactive ingredients may vary.